Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Colorectal Cancer and Inflammatory Bowel Disease
4.2.2 Minimally Invasive Nature of Therapy
4.2.3 Increasing Technological Advancements
4.3 Market Restraints
4.3.1 Possibility of Bowel Perforation
4.3.2 Lack of Awareness Among the Emerging Nations
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Mini Devices
5.1.2 Cone Devices
5.1.3 Bed Systems
5.1.4 Balloon Catheter Devices
5.2 By Patient
5.2.1 Children
5.2.2 Adults
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Clinics
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Consure Medical Pvt. Ltd.
6.1.2 ConvaTec Group PLC
6.1.3 Becton, Dickinson and Company
6.1.4 Aquaflush Medical Limited
6.1.5 Coloplast A/S
6.1.6 B. Braun Melsungen AG
6.1.7 MBH-International A/S
6.1.8 Wellspect HealthCare AB
6.1.9 ProSys International Ltd.
6.1.10 ABC Medical, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS